Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Mild to Moderately Active Crohn's Patients With Fistulas

NCT00321412 is registered in ClinicalTrials.gov with Ocera Therapeutics as lead sponsor.

NCT NCT00321412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00321412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Mild to Moderately Active Crohn's Patients With Fistulas
Lead sponsor
Ocera Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
September 30, 2008
Enrollment
191 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, intestinal fistula